Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation ( DrugBank: - )
2 diseases
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
93 | 原発性胆汁性胆管炎 | 1 |
296 | 胆道閉鎖症 | 1 |
93. 原発性胆汁性胆管炎
臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04522869 (ClinicalTrials.gov) | August 10, 2019 | 4/9/2019 | Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia | Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective Study | Primary Biliary Cirrhosis | Biological: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation | Vinmec Research Institute of Stem Cell and Gene Technology | Children's Hospital Number 2, Ho Chi Minh City, Vietnam | Recruiting | 5 Months | 2 Years | All | 34 | Phase 1/Phase 2 | Vietnam |
296. 胆道閉鎖症
臨床試験数 : 71 / 薬物数 : 70 - (DrugBank : 39) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 60
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04522869 (ClinicalTrials.gov) | August 10, 2019 | 4/9/2019 | Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia | Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective Study | Primary Biliary Cirrhosis | Biological: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation | Vinmec Research Institute of Stem Cell and Gene Technology | Children's Hospital Number 2, Ho Chi Minh City, Vietnam | Recruiting | 5 Months | 2 Years | All | 34 | Phase 1/Phase 2 | Vietnam |